![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
GOG-0209
GOG-0209, NCT00063999
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
GYN03-0177
NCT00506779
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
UTHSC-MS-96205
NCI-V97-1356, NCT00003135
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
UMN-2004LS021
UMN-WCC-38, NCT00258362
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
HSC-MS-01-111
HSC-MS-01-111, NCT00178802
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
06US03IMP-852A [Cooley]
MT2006-02, NCT00319748
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
PMH-PHL-062
7713, PHL-062, NCT00478426
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
2006-0211
NCT00392769
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
2003-0823
NCT00388154
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
CINJ-3330
NCT00161187
![](https://webarchive.library.unt.edu/eot2008/20081017061004im_/http://www.cancer.gov/images/spacer.gif)
|
|